IPO Announced

Eikon Therapeutics IPO

US$381m raised

Lodged 4 Feb 2026 · NASDAQ: EIKN · US$18.00 per share

Advisers

Eikon Therapeutics

Issuer

Legal adviser
Issuer
Eikon Therapeutics
Issuer based in
United States
Sector
Oncology
Tags
Oncology, Biotech, Drug Development

Similar deals

All oncology deals →

Sources

Suggest a correction

A missing adviser, a wrong role or a different outcome. A link to a public source helps.